Orion Corporation, commonly referred to as Orion, is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, Orion has established itself as a key player in the pharmaceutical and biotechnology industry, with a strong presence in Europe and beyond. The company focuses on developing innovative medicines and diagnostic products, particularly in the fields of oncology, pain management, and central nervous system disorders. Orion's core offerings include prescription pharmaceuticals and over-the-counter products, distinguished by their commitment to quality and research-driven development. With a robust pipeline of new therapies and a reputation for excellence, Orion has achieved notable milestones, including successful collaborations and a growing international market presence. As a trusted name in healthcare, Orion continues to advance its mission of improving patient outcomes through science and innovation.
How does Orion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Orion's score of 69 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Orion Corporation reported total greenhouse gas emissions of approximately 371,000,000 kg CO2e, comprising 5,625,000 kg CO2e from Scope 1, 5,330,000 kg CO2e from Scope 2 (market-based), and a significant 361,961,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions include substantial contributions from purchased goods and services (about 277,588,000 kg CO2e) and upstream transportation and distribution (approximately 25,426,000 kg CO2e). Orion has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 75% by 2025, using 2016 as the baseline year. This target is part of a broader strategy to achieve net-zero emissions by 2050. Additionally, the company has committed to reducing its absolute Scope 1 and 2 emissions by 70% by 2030 from a 2023 base year, as part of its Science Based Targets initiative (SBTi) commitments. Furthermore, Orion aims for 78% of its suppliers, covering emissions from purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2029. Overall, Orion's emissions data and climate commitments reflect a proactive approach to sustainability, aligning with industry standards and global climate goals.
Access structured emissions data, company-specific emission factors, and source documents
2007 | 2008 | 2009 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 3,740,000 | 0,000,000 | 0,000,000 | - | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 21,685,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 000,000,000 | - | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orion is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.